|
2023-08-22 |
2023-08-21 |
B
Purchase
|
Kandera Reinhard
Chief Financial Officer
Executive Director
|
7,000
+19.4%
0.73
USD 5,075
|
7,000
+19.4%
|
0.73
|
USD 5,075
|
|
|
2023-08-17 |
2023-08-16 |
B
Purchase
|
Kandera Reinhard
Chief Financial Officer
Executive Director
|
8,000
+28.5%
0.71
USD 5,712
|
8,000
+28.5%
|
0.71
|
USD 5,712
|
|
|
2023-07-11 |
2023-07-11 |
B
Purchase
|
Aldag Jorn
Chief Executive Officer
Executive Director
|
5,000
+7.5%
0.83
USD 4,142
|
5,000
+7.5%
|
0.83
|
USD 4,142
|
|
|
2023-07-11 |
2023-07-07 |
B
Purchase
|
Aldag Jorn
Chief Executive Officer
Executive Director
|
5,000
+8.1%
0.81
USD 4,050
|
5,000
+8.1%
|
0.81
|
USD 4,050
|
|
|
2023-07-07 |
2023-07-05 |
B
Purchase
|
Aldag Jorn
Chief Executive Officer
Executive Director
|
5,000
+8.8%
0.89
USD 4,450
|
5,000
+8.8%
|
0.89
|
USD 4,450
|
|
|
2023-07-05 |
2023-07-03 |
B
Purchase
|
Aldag Jorn
Chief Executive Officer
Executive Director
|
5,000
+9.6%
0.89
USD 4,456
|
5,000
+9.6%
|
0.89
|
USD 4,456
|
|
|
2023-07-03 |
2023-06-30 |
B
Purchase
|
Kandera Reinhard
Chief Financial Officer
Executive Director
|
12,000
+74.6%
0.88
USD 10,560
|
12,000
+74.6%
|
0.88
|
USD 10,560
|
|
|
2022-01-12 |
2021-12-21 |
S
Sale
|
Matushansky Igor
Chief Medical Officer
Officer
|
2,205
-2.5%
2.49
USD 5,490
|
2,205
-2.5%
|
2.49
|
USD 5,490
|
|
|
2022-01-12 |
2021-12-21 |
S
Sale
|
Matushansky Igor
Chief Medical Officer
Officer
|
7,440
-8.1%
2.49
USD 18,526
|
7,440
-8.1%
|
2.49
|
USD 18,526
|
|
|
2022-01-12 |
2021-12-21 |
S
Sale
|
Matushansky Igor
Chief Medical Officer
Officer
|
5,304
-6.2%
2.49
USD 13,207
|
5,304
-6.2%
|
2.49
|
USD 13,207
|
|
|
2021-04-23 |
2021-04-21 |
S
Sale
|
SOFINNOVA CAPITAL VI FCPR
Large shareholder
|
328,620
-9.4%
11.60
USD 3,812,386
|
328,620
-9.4%
|
11.60
|
USD 3,812,386
|
|
|
2021-03-29 |
2021-03-25 |
PS
Planned sale
|
SOFINNOVA CAPITAL VI FCPR
Large shareholder
|
28,546
-0.8%
13.12
USD 374,569
|
28,546
-0.8%
|
13.12
|
USD 374,569
|
|
|
2021-03-26 |
2021-03-24 |
PS
Planned sale
|
SOFINNOVA CAPITAL VI FCPR
Large shareholder
|
52,690
-1.4%
13.70
USD 721,616
|
52,690
-1.4%
|
13.70
|
USD 721,616
|
|
|
2021-03-25 |
2021-03-23 |
PS
Planned sale
|
SOFINNOVA CAPITAL VI FCPR
Large shareholder
|
40,000
-1.1%
13.91
USD 556,476
|
40,000
-1.1%
|
13.91
|
USD 556,476
|
|
|
2021-03-24 |
2021-03-22 |
PS
Planned sale
|
SOFINNOVA CAPITAL VI FCPR
Large shareholder
|
40,534
-1.1%
14.54
USD 589,263
|
40,534
-1.1%
|
14.54
|
USD 589,263
|
|
|
2021-03-23 |
2021-03-19 |
PS
Planned sale
|
SOFINNOVA CAPITAL VI FCPR
Large shareholder
|
166,230
-4.3%
14.60
USD 2,427,739
|
166,230
-4.3%
|
14.60
|
USD 2,427,739
|
|
|
2020-12-18 |
2020-12-17 |
S
Sale
|
Matushansky Igor
Chief Medical Officer
Officer
|
16,478
-17.6%
11.76
USD 193,781
|
16,478
-17.6%
|
11.76
|
USD 193,781
|
|
|
2020-12-18 |
2020-12-17 |
S
Sale
|
Matushansky Igor
Chief Medical Officer
Officer
|
11,501
-15.2%
11.70
USD 134,562
|
11,501
-15.2%
|
11.70
|
USD 134,562
|
|
|
2020-12-18 |
2020-12-16 |
S
Sale
|
Matushansky Igor
Chief Medical Officer
Officer
|
380
-0.7%
11.70
USD 4,446
|
380
-0.7%
|
11.70
|
USD 4,446
|
|
|
2020-10-06 |
2020-10-02 |
PS
Planned sale
|
SOFINNOVA CAPITAL VI FCPR
Large shareholder
|
300
-0.0%
10.00
USD 3,000
|
300
-0.0%
|
10.00
|
USD 3,000
|
|
